The title of the patent is: “AUGMENTATION OF ANTIINFLAMMATORY, IMMUNOMODULATORY, AND REGENERATIVE PROCESSES IN AMYOTROPHIC LATERAL SCLEROSIS USING XENON AND NOBLE GAS COMBINATIONS”. It is scheduled to issue on August 13, 2019.

The company is looking forward to the finalization of this patent’s prosecution and intends to add ALS to its growing list of promising treatment indications.